More on CGTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.6 Score)

Upcoming Events

- Earnings (8/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cognition Therapeutics, Inc. (NQ:CGTX)
Delayed: 1.03 -0.01 (0.96%)
Prev. Close $1.04  
Open$1.05 
52 Wk High$ 
52 Wk Low$ 
Day High$1.05 
Day Low$1.00 
P/E N/A  
EPS$ 
Volume508,695 

Friends, Peers and Foes (?): COCP, FBLG, PDSB, TNXP, 6XB2 (more...)

Mar 2, 2026 07:36 AM Form 8-K COGNITION THERAPEUTICS For: Mar 02
Mar 2, 2026 07:31 AM Cognition Therapeutics advances DLB psychosis program for zervimesine
Mar 2, 2026 07:30 AM Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
Feb 18, 2026 04:17 PM Form 4 COGNITION THERAPEUTICS For: Feb 15 Filed by: Ricciardi Lisa
Feb 18, 2026 04:17 PM Form 4 COGNITION THERAPEUTICS For: Feb 15 Filed by: Doyle John Brendan
Feb 18, 2026 04:16 PM Form 4 COGNITION THERAPEUTICS For: Feb 15 Filed by: Caggiano Anthony
Feb 5, 2026 05:28 PM Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Ricciardi Lisa
Feb 5, 2026 05:27 PM Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Doyle John Brendan
Feb 5, 2026 05:26 PM Form 4 COGNITION THERAPEUTICS For: Feb 03 Filed by: Caggiano Anthony
Feb 5, 2026 07:31 AM Cognition Therapeutics extends drug access program for dementia patients
View All Articles

Entities mentioned with CGTX

View All Entities